A dose of private equity is apparently just what the doctor ordered. On Tuesday, UK-based PE firm Vitruvian Partners made a $637 million strategic investment in DeepIntent, a health care-focused demand-side platform that specializes in helping pharma brands reach patients and providers using programmatic advertising. Although Vitruvian’s portfolio includes a bunch of software, consumer tech […]
The post Health Care DSP DeepIntent Sells $637 Million Majority Stake To PE Firm Vitruvian Partners appeared first on AdExchanger.
